PUBLIKACJE

 

2018

  1. Boncler M, Kehrel B, Szewczyk R, Stec-Martyna E, Bednarek R, Brodde M, Watała C. “Oxidation of C-reactive protein by hypochlorous acid leads to the formation of potent platelet activator”. Int J Biol Macromol. 2018, 107(Pt B), 2701-2714.
  2. Wilczyński M, Danielska J, Domańska-Senderowska D, Dzieniecka M, Szymańska B, Malinowski A. „Association of miRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer”. Acta Obstet Gynecol Scand. 2018. [Epub ahead of print].
  3. Uznańska-Loch B, Wikło K, Kulczycka-Wojdala D, Szymańska B, Chrzanowski Ł, Wierzbowska-Drabik K, Trzos E, Kasprzak J, Kurpesa M. „Genetic variants in the Polish population of patients with pulmonary arterial hypertension - sequencing of BMPR2, ALK1 and ENG genes”. Kardiol Pol. 2018. [Epub ahead of print].
  4. Wilczyński M, Żytko E, Danielska J, Szymańska B, Dzieniecka M, Nowak M, Malinowski J, Owczarek D, Wilczyński J. Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer. Arch Gynecol Obstet. 2018. [Epub ahead of print].

2017

  1. Papiewska-Pająk I, Balcerczyk A, Stec-Martyna E, Koziołkiewicz W, Boncela J. “Vascular endothelial growth factor-D modulates oxidant-antioxidant balance of human vascular endothelial cells”. J Cell Mol Med. 2017, 21(6), 1139-1149.
  2. Długosz A, Gach K, Szymański J, Modranka J, Janecki T, Janecka A.Anticancer activity of new molecular hybrids combining 1,4-naphthalenedione motif with phosphonic acid moiety in hepatocellular carcinoma HepG2 cells”. Acta Biochim Pol. 2017, 64(1), 41-48.
  3. Berent D, Emilien G, Podgórski M, Kusideł E, Kulczycka-Wojdala D, Szymańska B, Macander M, Pawłowska Z. “SSTR4, childhood adversity, self-efficacy and suicide risk in alcoholics”. Translational Neuroscience. 2017, 8, 76-86.
  4. Drobnik J, Pietrucha K, Kudzin M, Mader K, Szymański J, Szczepanowska A. “Comparison of various types of collagenous scaffolds applied for embryonic nerve cell culture”. Biologicals. 2017, 46, 74-80.
  5. Drobnik J, Pietrucha K, Piera L, Szymański J, Szczepanowska A. “Collagenous scaffolds supplemented with hyaluronic acid and chondroitin sulfate used for wound fibroblast and embryonic nerve cell culture”. Adv Clin Exp Med. 2017, 26(2), 223-230.
  6. Księżakowska-Łakoma K, Kulczycka-Wojdala D, Kulig A, Baum M, Wilczyński J. „The presence of A5935G, G5949A, G6081A, G6267A, T9540C mutations in MT-CO1 and MT-CO3 genes and other variants of MT-CO1 and MT-CO3 gene fragments in the study population diagnosed with endometrial cancer”. Ginekol Pol. 2017, 88(7), 343-348.
  7. Owczarek K, Hrabem E, Fichna J, Sosnowska D, Koziołkiewicz M, Szymański J, Lewandowska U. „Flavanols from Japanese quince (Chaenomeles japonica) fruit suppress expression of cyclooxygenase-2, metalloproteinase-9, and nuclear factor-kappaB in human colon cancer cells”. Acta Biochimica Polonica. 2017, 64(3), 567-576.
  8. Wilczyński M, Żytko E, Szymańska B, Dzieniecka M, Nowak M, Danielska J, Stachowiak G, Wilczyński J. “Expression of miR-146a in patients with ovarian cancer and its clinical significance”. Oncology Letters. 2017, 14, 3207-3214.
  9. Długosz A, Gach-Janczak K, Szymański J, Deredas D, Krawczyk H, Janecki T, Janecka A. “Anticancer properties of a new hybrid analog AD-013 combining a coumarin scaffold with an α-methylene-δ-lactone motif”. Anticancer Agents Med Chem. 2017, [Epub ahead of print].
  10. Berent D, Podgórski M, Kulczycka-Wojdala D, Kusideł E, Macander M, Pawłowska Z. “Childhood adversities are not a predictors of SSTR4met in alcoholics”. Translational Neuroscience. 2017, 8, 127-138.

2016

  1. Kassassir H, Siewiera K, Talar M, Stec-Martyna E, Pawłowska Z, Watała C. “Non-enzymatic modifications of prostaglandin H synthase 1 affect bifunctional enzyme activity - Implications for the sensitivity of blood platelets to acetylsalicylic acid”. Chemico-Biological Interactions. 2016, 253, 78-92.
  2. Gach K, Modranka J, Szymański J, Pomorska D, Krajewska U, Mirowski M, Janecki T, Janecka A. „Anticancer properties of new synthetic hybrid molecules combining naphtho[2,3-b]furan-4,9-dione or benzo[f]indole-4,9-dione motif with phosphonate subunit”. Eur J Med Chem. 2016, 14, 51-63.
  3. Gach K, Grądzka I, Wasyk I, Męczyńska-Wielgosz S, Iwaneńko T, Szymański J, Koszuk J, Janecki T, Kruszewski M, Janecka A. „Anticancer activity and radiosensitization effect of methyleneisoxazolidin-5-ones in hepatocellular carcinoma HepG2 cells”. Chem Biol Interact. 2016, 248, 68-73.
  4. Błaszczak-Świątkiewicz K, Sikora J, Szymański J, Danilewicz M, Mikiciuk-Olasik E. „Erratum to: Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives”. Tumour Biol. 2016, 37(6), 8467-8468.
  5. Błaszczak-Świątkiewicz K, Sikora J, Szymański J, Danilewicz M, Mikiciuk-Olasik E. „Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives”. Tumour Biol. 2016, 37(8), 11135-11145.
  6. Zawlik I, Gablo N, Szymańska B, Pawłowska Z, Chudobiński C, Chałubińska-Fendler J, Morawiec Z, Zielińska-Bliźniewska H, Morawiec-Sztandera A, Kołacińska A. „Immune checkpoints in aggressive breast cancer subtypes”. Neoplasma. 2016, 63(5), 768-773.
  7. Wójcik K, Piekarska A, Szymańska B, Jabłonowska E. „Hepatic expression of miR-122 and antioxidant genes in patients with chronic hepatitis B”. Acta Biochim Pol. 2016, 63(3), 527-531.
  8. Wilczyński M, Danielska J, Dzieniecka M, Szymańska B, Wojciechowski M, Malinowski A. „Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer”. PLoS One. 2016, Oct13; 11(10):e0164687.doi:10.1371 /journal.pone.0164687.

2015

  1. Gach K, Szymański J, Pomorska D, Długosz A, Modranka J, Janecki T, Janecka A. „Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells”. Tumor Biol. 2015, 36(8), 5971-5977.
  2. Kołacińska A, Cebula-Obrzut B, Pakuła L, Chałubińska-Fendler J, Morawiec-Sztandera A, Pawłowska Z, Zawlik I, Morawiec Z, Jesionek-Kupnicka D, Smolewski P. „Immune checkpoints in breast cancer surgery”. Oncology Letters. 2015, 10(2), 1079-1086.
  3. Pawełczyk T, Szymańska B, Grancow-Grabka M, Kotlicka-Antczak M, Pawełczyk A. “Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia”. Neuropsychiatr Dis Treat. 2015, 11, 1493-1503.
  4. Gach K, Szymański J, Pomorska D, Długosz A, Modranka J, Michalak M, Janecki T, Janecka A. „Anticancer Properties of Novel 4-methylene-1,2-diphenylpyrazolidin-3-ones”. Chem Biol Drug Des. 2015, 86(5), 961-968.

2014

  1. Jabłonowska E, Wójcik K, Koślińska-Berkan E, Szymańska B, Omulecka A, Piekarska A. „Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection”. Arch Virol. 2014, 159(6), 1365-1371.
  2. Kołacinska A, Morawiec J, Fendler W, Małachowska B, Morawiec Z, Szemraj J, Pawłowska Z, Chowdhury D, Choi YE, Kubiak R, Pakuła L, Zawlik I. „Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report”. Mol Biol Rep. 2014, 41(5), 2851-2857.
  3. Olszewska P, Szymański J, Mikiciuk-Olasik E, Szymański P. „New cyclopentaquinoline derivatives with fluorobenzoic acid induce G1 arrest and apoptosis in human lung adenocarcinoma cells”. Eur J Pharmacol. 2014, 729, 30-36.
  4. Wyrębska A, Pawłowska Z, Gach K, Komorowski P, Protas A, Walkowiak B, Janecka A.  „Proteomic Analysis of Proteins Engaged in α-Methylene-δ-Lactone Cytotoxic Effects in Hormone-Independent Breast Cancer MDA-MB-231 Cells”. Chemical Biology & Drug Design. 2014, 84(3), 300-306.
  5. Kołacińska A, Morawiec J, Pawłowska Z, Szemraj J, Szymańska B, Małachowska B, Morawiec Z, Pakuła L, Kubiak R, Zawlik I. „Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients”. DNA and Cell Biology. 2014, 33(9), 624-629.
  6. Jabłonowska E, Wójcik K, Szymańska B, Omulecka A, Cwiklińska H, Piekarska A. „Hepatic HMOX1 Expression Positively Correlates with Bach-1 and miR-122 in Patients with HCV Mono and HIV/HCV Coinfection”. PLoS One. 2014, 2014 Apr 21;9(4):e95564. doi: 10.1371/journal.pone.0095564
  7. Babińska A, Clement C, Świątkowska M, Szymański J, Shon A, Ehrlich Y, Kornecki E, Salifu M. „Development of new anti-atherosclerotic and anti-thrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides”. Biopolymers. 2014, 102(4), 322-334.
  8. Olszewska P, Mikiciuk-Olasik E, Błaszczak-Świątkiewicz K, Szymański J, Szymański P. „Novel tetrahydroacridine derivatives inhibit human lung adenocarcinoma cell growth by inducing G1 phase cell cycle arrest and apoptosis”. Biomed Pharmacother. 2014, 68(8), 959-967.

2013

  1. Jesionek-Kupnicka D, Szybka M, Potemski P, Kulczycka-Wojdala D, Jaskólski D, Bieńkowski M, Skowroński W, Papierz W, Kordek R, Zawlik I. „Association of loss of heterozygosity with shorter survival in primary glioblastoma patients”. Pol J Pathol. 2013, 64(4), 268-275.
  2. Stawski R, Piaskowski S, Ewelina Stoczyńska-Fidelusa, Bieńkowski M, Zakrzewska M, Och W, Jaskólski D, Papierz W, Sikorska B, Rieske P Liberski P. „Reduced expression of ELAVL4 in male meningioma patients”. Brain Tumor Pathol. 2013, 30(3), 160-166.
  3. Matysiak M, Fortak-Michalska M, Szymańska B, Orłowski W, Jurewicz A, Selmaj K „MicroRNA-146a Negatively Regulates the Immunoregulatory Activity of Bone Marrow Stem Cells by Targeting Prostaglandin E2 Synthase-2”. J Immunol. 2013, 190(10), 5102-5109.
  4. Wyrębska A, Gach K, Lewandowska U, Szewczyk K, Hrabec E, Modranka J, Jakubowski R, Janecki T, Szymański J, Janecka A. „Anticancer Activity of New Synthetic α-Methylene-δ-Lactones on Two Breast Cancer Cell Lines”. Basic Clin Pharmacol Toxicol. 2013, 113(6), 391-400.
  5. Wyrębska A, Szymański J, Gach K, Piekielna J, Koszuk J, Janecki T, Janecka A. “Apoptosis-mediated cytotoxic effects of parthenolide and the new synthetic analog MZ-6 on two breast cancer cell lines”. Mol Biol Rep. 2013, 40(2), 1655-1663.
 

2012

  1. Jabłonowska E, Piekarska A, Koślińska-Berkan E, Omulecka A, Szymańska B, Wójcik K. “Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin”. Acta Biochim Pol. 2012, 59(3), 333-337.
  2. Kołacińska A, Fendler W, Szemraj J, Szymańska B, Borowska-Garganisz E, Nowik M, Chałubińska J, Kubiak R, Pawłowska Z, Błasinska-Morawiec M, Potemski P, Jeziorski A, Morawiec Z. “Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer”. Mol Biol Rep. 2012, 39(7), 7435-7441.
  3. Stec-Martyna E, Ponassi M, Miele M, Parodi S, Felli L, Rosano C. “Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics”. Curr Cancer Drug Targets. 2012, 12(6), 658-666.
  4. Kołacińska A, Chałubińska J, Zawlik I, Szymańska B, Borowska-Garganisz E, Nowik M, Fendler W, Kubiak R, Pawłowska Z, Morawiec Z, Szemraj J. ”Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer”. Neoplasma. 2012, 59(4), 424-432.

 

2011

  1. Witusik-Perkowska M, Rieske P, Hułas-Bigoszewska K, Zakrzewska M, Stawski R, Kulczycka-Wojdala D, Bieńkowski M, Stoczyńska-Fidelus E, Grešner S, Piaskowski S, Jaskólski D, Papierz W, Zakrzewski K, Kolasa M, Ironside J, Liberski P. “Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies”. J Neurooncol. 2011, 102(3), 395-407.
  2. Boncler M, Rywaniak J, Szymański J, Potempa L, Rychlik B, Watała C. “Modified C-reactive protein interacts with platelet glycoprotein Ibα”. Pharmacol Rep. 2011, 63(2), 464-475.
  3. Walkowiak B, Szymański W, Szymański J, Walczyńska M, Walkowiak-Przybyło M, Komorowski P, Okrój W, Jakubowski W, Kamińska M. “SPR biosensors technique supports development in biomaterials engineering. New Perspectives in Biosensors Technology and Applications”. 2011, Book 4, ed. Pier Andrea Serra, ISBN 978-953-307-448-1.
  4. Condorelli F, Stec-Martyna E, Zaborowska J, Felli L, Gemmi I, Ponassi M, Rosano C. “Role of the non-receptor tyrosine kinase fes in cancer”. Curr Med Chem. 2011, 18(19), 2913-2920.
  5. Rosano C, Stec-Martyna E, Lappano R, Maggiolini M. “Structure-based approach for the discovery of novel selective estrogen receptor modulators”. Curr Med Chem. 2011, 18(8), 1188-1194.
  6. Gresner S, Golańska E, Kulczycka-Wojdala D, Jaskólski D, Papierz W, Liberski P. „Selection of reference genes for gene expression studies in astrocytomas”. Anal Biochem. 2011, 408(1), 163-165.
  7. Witusik-Perkowska M, Rieske P, Hułas-Bigoszewska K, Zakrzewska M, Stawski R, Kulczycka-Wojdala D, Bieńkowski M, Stoczyńska-Fidelus E, Grešner S, Piaskowski S, Jaskólski J, Papierz W, Zakrzewski K, Kolasa M, Ironside J, Liberski P. “Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies”. J. Neurooncol. 2011, 102(3), 395-407.
  8. Nobusawa S, Stawski R, Kim YH, Nakazato Y, Ohgaki H. “Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study”. Neuropathology. 2011, 31(6), 583-588.
  9. Piaskowski S, Bieńkowski M, Stoczyńska-Fidelus E, Stawski R, Sieruta M, Szybka M, Papierz W, Wolańczyk M, Jaskólski D, Liberski P, Rieske P. “Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions”. Br J Cancer. 2011, 104(6), 968-970.

2010

  1. Ćwiklińska H, Mycko M, Szymańska B, Matysiak M, Selmaj K. „Aberrant stress-induced Hsp70 expression in immune cells in multiple sclerosis”. J Neurosci Res. 2010, 88(14), 3102-3110.
  2. Piaskowski S, Zawlik I, Szybka M, Kulczycka-Wojdala D, Stoczyńska-Fidelus E, Bieńkowski M, Robak T, Kusińska R, Jesionek-Kupnicka D, Kordek R, Rieske P, Liberski P. „Detection of P53 mutations in different cancer types is improved by cDNA sequencing”. Oncology Letters. 2010, 1, 717-721.